{
    "url_original": "https://www.wsj.com/articles/drugmaker-valo-health-acquires-biotech-startup-gaining-protein-technology-11627385401?mod=business_featst_pos3",
    "url": "drugmaker-valo-health-acquires-biotech-startup-gaining-protein-technology-11627385401",
    "title": "Drugmaker Valo Health Acquires Biotech Startup, Gaining Protein Technology",
    "sub_head": "Purchase of Courier Therapeutics gives Valo potential cancer drug",
    "time": "2021-07-27 07:30:00",
    "body": "Valo Health LLC, a drugmaker valued at about $2.8 billion that has agreed to go public by merging with a blank-check company, has acquired a biotechnology startup and diversified its pipeline.<br />Boston-based Valo has purchased Houston-based Courier Therapeutics Inc., gaining technology that could lead to protein treatments for cancer and autoimmune and inflammatory diseases.<br />Valo,..."
}